Cited by 12Health Systems, Economic Evaluations, Quality of LifeEconomic and Environmental ValuationPharmaceutical Economics and Policy

The DOI matches its Crossref record.

Recommendations on Perspectives for the Reference Case

Abstract

The original Panel recommended a societal Reference Case as a point of comparison across studies. The Second Panel reconsidered at length the perspectives that Reference Case analyses should use. Many, if not most published cost-effectiveness analyses (CEAs) have not used a true societal perspective. Further, decision-making bodies that have incorporated CEA into health technology assessment to inform coverage and reimbursement decisions have not adopted a societal perspective. Given this backdrop and various options, the Second Panel recommends that all studies report two Reference Case analyses: one based on a healthcare sector perspective and one based on a societal perspective. We recommend that analysts present all items in an analysis as disaggregated consequences in an Impact Inventory to ensure that all consequences, including those outside the formal healthcare sector, are considered regularly and comprehensively, as they have generally not been to date.

Overview

Integrity signals

Registry

Crossref · 10.1093/acprof:oso/9780190492939.003.0003

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

Sorted by citations

Metadata

Authors
Neumann, P. J., Sanders, G. D., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., Salomon, J. A., Sculpher, M. J., Trikalinos, T. A., Russell, L. B., Siegel, J. E., & Ganiats, T. G.
Venue
Cost-Effectiveness in Health and Medicine
Published
2016-12-12
Pages
67-74
OpenAlex
W2552997830
Cited by
12
References
0
Citations by year
2026: 1 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 4 · 2017: 1
FWCI
9.77
Type
book chapter
Language
en
Open access
closed
Locations
Oxford University Press eBooks (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
reference case, societal perspective, cost-effectiveness analysis, health technology assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review